During the past two and a half years, we’ve seen unparalleled innovation and private-public collaboration in the global fight against Covid-19. The rapid development and rollout of new vaccines, diagnostic tests, and therapeutics have saved millions of lives.
ADVERTISEMENT |
However, these developments haven’t benefited everyone equally. Although more than 67 percent of the global population has received at least one dose of the Covid-19 vaccine, disparities between higher and lower income countries are wide. As of May 2022, 72 percent of people in high-income countries have received one dose, compared to 18 percent in low-income countries, according to the United Nations Development Programme’s Global Dashboard for Vaccine Equity.
…
Add new comment